David M. Davidson

2.3k total citations · 1 hit paper
30 papers, 1.8k citations indexed

About

David M. Davidson is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, David M. Davidson has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in David M. Davidson's work include Microscopic Colitis (8 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Viral-associated cancers and disorders (4 papers). David M. Davidson is often cited by papers focused on Microscopic Colitis (8 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Viral-associated cancers and disorders (4 papers). David M. Davidson collaborates with scholars based in United States, Canada and United Kingdom. David M. Davidson's co-authors include Betsy J. Lahue, J. Jaime, Judith A. O’Brien, Elliott Kieff, Ellen Cahir-McFarland, Thomas Louie, Jimmy Duong, Stephanie L. Schauer, Stuart Johnson and Dale N. Gerding and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

David M. Davidson

27 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

2014 394 citations Stuart Johnson, Thomas Louie et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Davidson United States	17	994	845	375	307	233	30	1.8k
Shinsaku Sakurada Japan	20	468 0.5×	340 0.4×	225 0.6×	170 0.6×	284 1.2×	42	1.3k
Pak K. Hui China	12	800 0.8×	185 0.2×	196 0.5×	126 0.4×	216 0.9×	14	1.4k
Joe L. Hsu United States	17	213 0.2×	283 0.3×	400 1.1×	204 0.7×	93 0.4×	47	1.0k
Akiko Hori Japan	21	228 0.2×	288 0.3×	294 0.8×	74 0.2×	274 1.2×	61	1.3k
Flávio Steinwurz Brazil	17	635 0.6×	950 1.1×	312 0.8×	541 1.8×	534 2.3×	52	2.4k
Mohammad Varahram Iran	19	603 0.6×	308 0.4×	104 0.3×	160 0.5×	207 0.9×	66	1.5k
Federica Furfaro Italy	26	240 0.2×	1.1k 1.3×	348 0.9×	644 2.1×	315 1.4×	151	2.2k
Sergio Vañó‐Galván Spain	27	319 0.3×	397 0.5×	214 0.6×	166 0.5×	239 1.0×	211	2.7k
E. Susan Amirian United States	20	442 0.4×	299 0.4×	290 0.8×	166 0.5×	84 0.4×	52	1.4k
Ji Woong Son South Korea	27	365 0.4×	429 0.5×	258 0.7×	123 0.4×	373 1.6×	101	2.1k

Countries citing papers authored by David M. Davidson

Since Specialization

Citations

This map shows the geographic impact of David M. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Davidson more than expected).

Fields of papers citing papers by David M. Davidson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Davidson. The network helps show where David M. Davidson may publish in the future.

Co-authorship network of co-authors of David M. Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Davidson. A scholar is included among the top collaborators of David M. Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Davidson. David M. Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berman, Brian, et al.. (2020). Efficacy of aminolevulinic acid 20 % solution photodynamic therapy in the treatment of actinic keratoses on the upper extremities: A post hoc analysis of a phase 3, randomized, vehicle-controlled trial. Photodiagnosis and Photodynamic Therapy. 32. 102013–102013. 9 indexed citations

Menter, Alan, George J. Murakawa, Alan M. Mendelsohn, et al.. (2020). Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study. Journal of the European Academy of Dermatology and Venereology. 34(12). e803–e805. 8 indexed citations

Johnson, Stuart, Thomas Louie, Dale N. Gerding, et al.. (2014). Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials. Clinical Infectious Diseases. 59(3). 345–354. 394 indexed citations breakdown →

Cheknis, Adam, Susan P. Sambol, David M. Davidson, et al.. (2009). Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005–2007. Anaerobe. 15(6). 230–233. 48 indexed citations

Peppe, Jennifer, et al.. (2008). A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well‐tolerated in healthy volunteers: a randomized phase I trial. British Journal of Clinical Pharmacology. 66(1). 102–109. 9 indexed citations

O’Brien, Judith A., Betsy J. Lahue, J. Jaime, & David M. Davidson. (2007). The Emerging Infectious Challenge of Clostridium difficile-Associated Disease in Massachusetts Hospitals: Clinical and Economic Consequences. Infection Control and Hospital Epidemiology. 28(11). 1219–1227. 266 indexed citations

Davidson, David M., et al.. (2007). O331 Metronidazole and vancomycin outcomes for Clostridium difficile -associated diarrhoea in a US hospital database. International Journal of Antimicrobial Agents. 29. S69–S69. 5 indexed citations

Louie, Thomas, Jennifer Peppe, David A. Johnson, et al.. (2006). Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile-Associated Diarrhea. Clinical Infectious Diseases. 43(4). 411–420. 154 indexed citations

Barker, Robert H., Ramzi Dagher, David M. Davidson, & Judith K. Marquis. (2006). Review article: tolevamer, a novel toxin‐binding polymer: overview of preclinical pharmacology and physicochemical properties. Alimentary Pharmacology & Therapeutics. 24(11-12). 1525–1534. 32 indexed citations

10.

Bedi, Deepak G. & David M. Davidson. (2001). Plantar fibromatosis: Most common sonographic appearance and variations. Journal of Clinical Ultrasound. 29(9). 499–505. 17 indexed citations

11.

Cahir-McFarland, Ellen, David M. Davidson, Stephanie L. Schauer, Jimmy Duong, & Elliott Kieff. (2000). NF-κB inhibition causes spontaneous apoptosis in Epstein–Barr virus-transformed lymphoblastoid cells. Proceedings of the National Academy of Sciences. 97(11). 6055–6060. 231 indexed citations

12.

Kaye, Kenneth M., Kenneth M. Izumi, Hong Li, et al.. (1999). An Epstein-Barr Virus That Expresses Only the First 231 LMP1 Amino Acids Efficiently Initiates Primary B-Lymphocyte Growth Transformation. Journal of Virology. 73(12). 10525–10530. 68 indexed citations

13.

Sylla, Bakary S., Siu Chun Hung, David M. Davidson, et al.. (1998). Epstein–Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ. Proceedings of the National Academy of Sciences. 95(17). 10106–10111. 134 indexed citations

14.

Davidson, David M., et al.. (1994). OBSERVATIONS ON 200 SURGICAL CASES OF TARSAL TUNNEL SYNDROME. Clinics in Podiatric Medicine and Surgery. 11(4). 609–616. 8 indexed citations

15.

Davidson, David M., et al.. (1979). Test of Ability to Subordinate. Modern Language Journal. 63(5/6). 305–305. 3 indexed citations

16.

Davidson, David M. & Eric Clearinghouse on Languages. (1978). Current approaches to the teaching of grammar in ESL.

17.

Davidson, David M.. (1977). Sentence Combining in an ESL Writing Program. Journal of Basic Writing. 1(3). 49–62. 5 indexed citations

18.

Davidson, David M.. (1977). The effect of individual differences of cognitive style on judgments of document relevance. Journal of the American Society for Information Science. 28(5). 273–284. 30 indexed citations

19.

Carrel, Jean‐Pierre & David M. Davidson. (1973). Topical immunotherapy of recalcitrant verrucae. A new therapeutic approach. Journal of the American Podiatric Medical Association. 63(7). 293–296. 2 indexed citations

20.

Davidson, David M.. (1966). Negro Slave Control and Resistance in Colonial Mexico, 1519-1650. Hispanic American Historical Review. 46(3). 235–235. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact